Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
| ▸ | MMP8 | P22894 | 1/20 | 0.50 |
| ▸ | MMP13 | P45452 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.47 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12830396 | 0.82 | GAA (0.50) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL6490 | 0.80 | GAA (0.59) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL7186972 | 0.80 | GAA (0.59) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL4760574 | 0.79 | GAA (0.52) | GAACA1CA2MMP1MMP2 | |
| Water SCHEMBL3352692 | 0.78 | GAA (0.56) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL27524 | 0.78 | GAA (0.56) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL15256448 | 0.78 | GAA (0.56) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL9901122 | 0.78 | GAA (0.56) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL30862469 | 0.78 | GAA (0.56) | GAACA1CA2MMP1MMP2 | |
| SCHEMBL526315 | 0.77 | GAA (0.50) | GAACA1CA2MMP1MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118345122-A | Method for pretreating lignocellulose raw material by using p-toluenesulfonic acid-hydrogen peroxide and application | 中国石油化工股份有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-118146177-A | Preparation method of propiolactone | 万华化学集团股份有限公司 | 2024-06-07 | — | — | CN | claimed |
| EP-4192820-A1 | A PROCESS FOR PREPARATION OF OXAZOLE COMPOUNDS | DSM IP Assets B.V. (NL) | 2023-06-14 | — | — | EP | claimed |
| CN-111606883-A | Sulfur-containing compound based on glutarimide framework and application thereof | 上海科技大学 | 2020-09-01 | — | — | CN | claimed |
| US-20100041882-A1 | METHODS FOR SYNTHESIS OF ACYLOXYALKYL COMPOUNDS | XENOPORT, INC. (US) | 2010-02-18 | — | — | US | claimed |
| US-7662987-B2 | Oxidation of 1-acyl alkyl compound under anhydrous condition | XENOPORT, INC. (US) | 2010-02-16 | — | — | US | claimed |
| US-20050070715-A1 | Methods for synthesis of acyloxyalkyl compounds | ARBOR PHARMACEUTICALS, LLC | 2005-03-31 | — | — | US | claimed |
| EP-0600317-B1 | Process for the preparation of halogenated benzoic acids | HOECHST AG (DE) | 1997-03-12 | — | — | EP | claimed |
| US-5481032-A | Process for the preparation of halogenated benzoic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-01-02 | — | — | US | claimed |
| US-4463172-A | Process for producing 2-methyl cephem-2-em and 2-methylcephem-3-em derivitaves | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1984-07-31 | — | — | US | claimed |
| CN-118345122-A | Method for pretreating lignocellulose raw material by using p-toluenesulfonic acid-hydrogen peroxide and application | 中国石油化工股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118345122-A | Method for pretreating lignocellulose raw material by using p-toluenesulfonic acid-hydrogen peroxide and application | 中国石油化工股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118345122-A | Method for pretreating lignocellulose raw material by using p-toluenesulfonic acid-hydrogen peroxide and application | 中国石油化工股份有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118146177-A | Preparation method of propiolactone | 万华化学集团股份有限公司 | 2024-06-07 | — | — | CN | disclosed |
| US-11999890-B2 | Surfactants for electronics | ADVANSIX RESINS AND CHEMICALS LLC (US) | 2024-06-04 | — | — | US | disclosed |
| US-4069324-A | CEPHALOSPORIN ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1978-01-17 | — | — | US | disclosed |
| US-4014874-A | Process for the manufacture of 3-substituted thiomethyl-7-amino-2-cephem-4-carboxylic acid compound | CIBA-GEIGY CORPORATION (US) | 1977-03-29 | — | — | US | disclosed |
| US-4013650-A | PROCESS FOR THE MANUFACTURE OF 3-METHYLENE-CEPHAM COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1977-03-22 | — | — | US | disclosed |
| US-3989695-A | 7β-Amino-cepham-3-ol-4-carboxylic acid compounds | CIBA-GEIGY CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
| US-3932465-A | ANTIBIOTIC | CIBA-GEIGY CORPORATION (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070715-A1 | Methods for synthesis of acyloxyalkyl compounds | AADAC, CYP2D6, CYP3A7 | GAA 369/4885CA1 854/4885CA2 1296/4885 |
| US-11999890-B2 | Surfactants for electronics | STOM, ESPL1, SMURF1 | GAA 2680/4885CA1 1675/4885CA2 3242/4885 |
| US-20100041882-A1 | METHODS FOR SYNTHESIS OF ACYLOXYALKYL COMPOUNDS | AADAC, CYP2D6, CYP3A7 | GAA 369/4885CA1 854/4885CA2 1296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.